A student-run resource for reliable reports on the latest law and technology news

Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott 

Written By: Hyeongsu Park - Edited By: Kendra Albert

The market for therapeutic antibodies is projected to reach hundreds of billion dollars within the next several years. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history.

Read More...

Posted On Mar - 13 - 2014 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
smartflash

Apple Ordered to Pay

By Paulius Jurcys – Edited by Saukshmya Trichi Slip opinion Jury verdict ...

tech-042112-002-617x416

A Computer Programme

By Yaping Zhang – Edited by Jenny Choi On February 13, ...

Unknown

Flash Digest: News i

By Anne Woodworth Report Claims Facebook Privacy Policy in Violation of ...

Unknown

Federal Circuit Flas

By Amanda Liverzani PTO’s Statutory Interpretation on Patent Term Adjustment Upheld  In ...

Unknown

Alleged mastermind b

By Jens Frankenreiter – Edited by Katherine Kwong   U.S. v. ...